Quest Diagnostics (DGX) Earnings Call Transcript
With diligent execution of our strategy and a strong fourth quarter, we generated double-digit growth in revenues and earnings per share for the full year. In 2025, we expanded our category-defining clinical innovation to meet robust demand,
No discussion yet. Be the first to share your thoughts!